Innovation Center
EARLY ACCESSLocation: Boao Lecheng, Hainan
The “Hainan Policy” allows Ruijin specialists to prescribe FDA and EMA-approved treatments years before they receive general NMPA approval in mainland China.
China Care Support
THERAPY LIAISONService: Innovative Medicine Navigator
Navigating the Lecheng Pilot Zone requires precision. We coordinate between you, the clinical team in Shanghai/Hainan, and the drug providers to ensure seamless access.